InflaRx IFRX
NASDAQ IFRX
$1.56 +0.03 (+1.96%)
At close: Oct 23, 2026 · 4:00 PM EDT

InflaRx (IFRX) Cash from Investing Activities (2016 - 2026)

Updated

InflaRx (IFRX) posted Cash from Investing Activities of $14.94 million for Q2 2026, compared with -$28.19 million a year earlier and up 107.9% from the prior quarter.

Analysis

InflaRx (IFRX) Cash from Investing Activities (2016 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cash from Investing Activities at InflaRx was $3.76 trillion, down 93.3% year-over-year; for FY2025, it was $3.65 trillion, down 93.5% from FY2024.

  • Annual Cash from Investing Activities shows a five-year compound annual growth rate of 974.8% (FY2020 to FY2025).
  • In prior years, InflaRx's Cash from Investing Activities was $55.96 trillion in FY2024, -$19.04 trillion in FY2023, $19.75 trillion in FY2022 and -$29.69 million in FY2021.
  • Quarterly Cash from Investing Activities has run from a low of -$19.04 trillion in Q4 2023 to a high of $55.96 trillion in Q4 2024 over five years.
  • On a year-over-year basis, Cash from Investing Activities increased in 1 of the last five quarters, with an average decline of 27.2%.
  • The strongest year-over-year quarter for Cash from Investing Activities in the past five years was Q3 2024, with growth of 139.1%; the weakest was Q4 2025, with a decline of 93.3%.
  • According to Business Quant data, Cash from Investing Activities for the three prior quarters was $7.19 million (Q1 2026), $3.76 trillion (Q4 2025) and $3.04 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn -2.71 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -1.20 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -2.91 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -10.35 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.11 Bn
10 InflaRx 112.78 Mn -220.84 Mn 2.74 Mn 14.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.94 Mn
Mar 31, 2026 7.19 Mn
Dec 31, 2025 9.17 Mn
Sep 30, 2025 3.04 Mn
Jun 30, 2025 -28.19 Mn
Mar 31, 2025 18.57 Mn
Dec 31, 2024 2.09 Mn
Sep 30, 2024 19.19 Mn
Jun 30, 2024 6.45 Mn
Mar 31, 2024 29.27 Mn
Dec 31, 2023 3.04 Mn
Sep 30, 2023 8.02 Mn
Jun 30, 2023 -26.47 Mn
Mar 31, 2023 -3.85 Mn
Dec 31, 2022 1.84 Mn
Sep 30, 2022 5.04 Mn
Jun 30, 2022 -14.86 Mn
Mar 31, 2022 29.72 Mn
Dec 31, 2021 -38.51 Mn
Sep 30, 2021 11.39 Mn
API Access

InflaRx Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=IFRX&period=max&api_key=YOUR_API_KEY